Work

Prolonged Cytopenias after Commercial CAR T-Cell Therapy with Tisagenlecleucel and Axicabtagene Ciloleucel for Relapsed and Refractory DLBCL

Year: 2023

Type: article

Source: Transplantation and Cellular Therapy

DOI: 10.1016/s2666-6367(23)00355-x

Authors: Gurusidda Manu, Anusha Vallurupalli, Staci Williamson, Jamie Brower, Veronika Bachanova, Joseph P. McGuirk, Loretta J. Nastoupil, Dr. Olalekan O. Oluwole, David L. Porter, Peter A. Riedell, Michael R. Bishop, Miguel-Angel Perales, Richard T Maziarz

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650

OpenAlex ID: W4319263151

FWCI: 0.105

Cites:

Cited by: 1

Related to: 10